Lava Therapeutics Nv Share Price

NASDAQ: LVTX

Small Cap

$1.54

(+0.32%)

as on September 13, 2025 at 1:26 am IST

$₹

Lava Therapeutics Nv Stock Performance

as on September 13, 2025 at 1:26 am IST

Day's Low
Day's High
$1.53
Day's Price Range
$1.56
$1.54
0.65%
Downside
1.30%
Upside
52 Week's Low
52 Week's High
$0.85
52-Week Price Range
$2.09
$1.54
44.79%
Downside
35.91%
Upside

Lava Therapeutics Nv share price movements today

Previous Close: $1.54
Open: $1.55
Volume: 305.4K
Day's Low - High: $1.53 - $1.56
52 Week Low - High: $0.85 - $2.09

Lava Therapeutics Nv Historical Returns

1 Month Return: + 0.98 %
3 Month Return: + 17.94 %
1 Year Return: -10.17 %
3 Year Return: -37.2 %
5 Year Return: 0 %

Lava Therapeutics Nv Stock Fundamentals & Key Indicators

Check Lava Therapeutics Nv market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$40.5M

EPS (TTM)

-0.726

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-25.7M

Revenue (TTM)

5.0M

Profit Margin

0.00%

Return On Equity TTM

21133600.00%

Lava Therapeutics Nv vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lava Therapeutics Nv with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lava Therapeutics Nv	BUY	$40.5M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	280.5%	-505.15	-12.96%
Beone Medicines Ltd	NA	$37.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	54.04%	28.08	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	2.03%	14.11	31.37%

Stock Returns calculator for Lava Therapeutics Nv Stock including INR - Dollar returns

The Lava Therapeutics Nv stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lava Therapeutics Nv investment value today

Current value as on today

₹94,674

Returns

₹5,326

(-5.33%)

Returns from Lava Therapeutics Nv Stock

₹10,465 (-10.47%)

Dollar Returns*

₹5,139 (+5.14%)

Analyst Recommendation on Lava Therapeutics Nv Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Lava Therapeutics Nv. Average target price of $1.39

Lava Therapeutics Nv Share Price Target

Get share price movements and forecasts by analysts on Lava Therapeutics Nv.

What analysts predicted

-10.79%DOWNSIDE

Target Price

$1.39

Current Price

$1.54

Analyzed by

11 Analysts

Target

$1.39

Lava Therapeutics Nv target price $1.39, a slight downside of -10.79% compared to current price of $1.54. According to 11 analysts rating.

Lava Therapeutics Nv Stock's Interest Amongst Investors

Search interest for Lava Therapeutics Nv Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 16, 2025 to September 15, 2025

Change:-41% versus previous 30 day period

Lava Therapeutics Nv Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	1	5	0	0	7	0	-	4	-	-
Gross Profit	0	2	0	0	7	0	0	-19	0	0
Operating Income	-13	-13	-10	-5	-1	-9	-11	-7	-7	-7
EBITDA	-13	-13	-10	-5	-1	-9	-11	-3	-3	-8
Interest Expense	10	-	-	-	0	0	-	0	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-13	-12	-8	-6	0	-8	-12	-3	-3	-8
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-14	-13	-9	-7	0	-8	-13	-3	-3	-8
Net Profit Margin	-1138.89%	-247.13%	-16671.70%	-1840.79%	-7.91%	-3638.61%	0.00%	-79.54%	0.00%	0.00%

Lava Therapeutics Nv Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	4	5	20	7	11
Gross Profit	-9	-14	5	20	3	11
Operating Income	-9	-14	-44	-34	-43	-29
EBITDA	-9	-14	-43	-30	-40	-23
Interest Expense	0	0	0	0	0	0
Depreciation	0	0	0	0	1	0
Income Before Tax	-9	-15	-45	-31	-41	-24
Income Tax Expense	0	0	0	0	0	0
Net Income	-10	-19	-51	-33	-45	-25
Net Profit Margin	0.00%	-425.06%	-906.94%	-164.55%	-620.09%	-209.60%

Lava Therapeutics Nv Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-12	-8	-6	0	-8	-12	-4	-3	-8
Operating Cash Flow	-13	-7	-10	-1	-8	-8	-1	-11	-13
Investing Cash Flow	0	-16	-8	0	0	0	10	15	-2
Financing Cash Flow	0	0	0	0	0	0	0	-	-
Change in Cash	-12	-24	-18	-1	-8	-8	8	4	-13

Lava Therapeutics Nv Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-15	-51	-31	-41	-25
Operating Cash Flow	-9	-32	4	-38	-19
Investing Cash Flow	0	-49	9	-17	12
Financing Cash Flow	18	171	0	0	0
Change in Cash	8	85	9	-56	-9

Global Institutional Holdings in Lava Therapeutics Nv

Funds	Holdings
Redmile Group, LLC	7.89%
BML Capital Management LLC	7.45%
Sanofi	7.3%
Merck & Co Inc	4.37%
Bruce & Co Inc	1.98%

See all

Insights on Lava Therapeutics Nv

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 227.99K → 4.99M (in $), with an average increase of 95.4% per quarter
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 157.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 86.5%
NEGATIVE IMPACT
Price Dip
In the last 3 years, LVTX stock has moved down by -34.4%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -3.47M → -8.63M (in $), with an average decrease of 148.3% per quarter

About Lava Therapeutics Nv

LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

Organisation	Lava Therapeutics Nv
Headquarters	Yalelaan 62, Utrecht, Netherlands, 3584 CM
Industry	Services
CEO	Mr. Stephen Allen Hurly M.B.A., M.Sc.
E-voting on shares	Click here to vote

Key Management of Lava Therapeutics Nv

Name	Title
Mr. Stephen Allen Hurly M.B.A., M.Sc.	CEO, President & Executive Director
Mr. Fred M. Powell CPA	Chief Financial Officer
Dr. Charles Q. Morris M.D., MBChB, MRCP (UK), Ph.D.	Chief Medical Officer
Ms. Oxana Polyakova Ph.D.	Chief Scientific Officer
Ms. Amy Garabedian J.D.	General Counsel & Corporate Secretary
Dr. Hans van der Vliet M.D., Ph.D.	Head of Innovation
Dr. Ton Adang Ph.D.	Chief Development Officer

FAQs

What is Lava Therapeutics Nv share price today?

Lava Therapeutics Nv share price today is $1.54 as on September 13, 2025 at 1:26 am IST at the close of the market. Lava Therapeutics Nv share today touched a day high of $1.56 and a low of $1.53.

What is the 52 week high and 52 week low for Lava Therapeutics Nv share?

Lava Therapeutics Nv share touched a 52 week high of $2.09 on October 23, 2024 and a 52 week low of $0.85 on February 12, 2025. Lava Therapeutics Nv stock price today i.e. September 13, 2025 at 1:26 am IST is closed at $1.54,which is 26.42% down from its 52 week high and 81.13% up from its 52 week low.

What is Lava Therapeutics Nv's market capitalisation today?

Lava Therapeutics Nv market capitalisation is $0.00T as on September 13, 2025 at 1:26 am IST.

How to invest in Lava Therapeutics Nv Stock (LVTX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lava Therapeutics Nv on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lava Therapeutics Nv Shares that will get you 0.9740 shares as per Lava Therapeutics Nv share price of $1.54 per share as on September 13, 2025 at 1:26 am IST.

What is the minimum amount required to buy Lava Therapeutics Nv Stock (LVTX) from India?

Indian investors can start investing in Lava Therapeutics Nv (LVTX) shares with as little as ₹88.27 or $1 (as of September 15, 2025 at 8:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Lava Therapeutics Nv stock (as per the Rupee-Dollar exchange rate as on September 15, 2025 at 8:42 am IST). Based on Lava Therapeutics Nv share’s latest price of $1.54 as on September 13, 2025 at 1:26 am IST, you will get 6.4935 shares of Lava Therapeutics Nv. Learn more about fractional shares .